ArticleBlood2019
Familial predisposition to TP53/complex karyotype MDS and leukemia in DNA repair-deficient xeroderma pigmentosum.
Open access · bronzeAbstract readLetter
In one paragraph
Article in Blood, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.
0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 42 citations in OpenAlex.
- Germline and somatic genetic landscape of pediatric myelodysplastic syndromes.Haematologica · 2025Review
- UVA-light-induced mutagenesis in the exome of human nucleotide excision repair-deficient cells.Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology · 2025Article
- Update on Recommendations for Cancer Screening and Surveillance in Children with Genomic Instability Disorders.Clinical cancer research : an official journal of the American Association for Cancer Research · 2024Review
- Update on Recommendations for Surveillance for Children with Predisposition to Hematopoietic Malignancy.Clinical cancer research : an official journal of the American Association for Cancer Research · 2024Review
- Diffuse large B-cell lymphoma with cutaneous involvement in a patient with xeroderma pigmentosum type C.JAAD case reports · 2024Article
- The French Cohort of DNA Repair-Deficient Xeroderma Pigmentosum Patients: Risk of Hematological Malignancies.Cancers · 2023Article
- Genetic Predisposition to Hematologic Malignancies in Childhood and Adolescence.Mediterranean journal of hematology and infectious diseases · 2023Review
- Verrucous Carcinoma of Tongue in Xeroderma Pigmentosum: A Case Report and Literature Review.Cureus · 2022Article
- Article
- Increased risk of internal tumors in DNA repair-deficient xeroderma pigmentosum patients: analysis of four international cohorts.Orphanet journal of rare diseases · 2022Article
- Xeroderma pigmentosum: an updated review.Drugs in context · 2022Review
- Lessons From Pediatric MDS: Approaches to Germline Predisposition to Hematologic Malignancies.Frontiers in oncology · 2022Review
- Xeroderma Pigmentosum Complementation Group C (XPC): Emerging Roles in Non-Dermatologic Malignancies.Frontiers in oncology · 2022Review
- Thyroid nodules in xeroderma pigmentosum patients: a feature of premature aging.Journal of endocrinological investigation · 2021Article
- MultiVERSE: a multiplex and multiplex-heterogeneous network embedding approach.Scientific reports · 2021Article
- Xeroderma Pigmentosum: A Model for Human Premature Aging.The Journal of investigative dermatology · 2021Review
- Molecular Targeted Therapy in Myelodysplastic Syndromes: New Options for Tailored Treatments.Cancers · 2021Review
- XPC and POLH/XPV Genes Mutated in a Genetic Cluster of Xeroderma Pigmentosum Patients in Northeast Brazil.Frontiers in genetics · 2021Article
- XPC deficiency increases risk of hematologic malignancies through mutator phenotype and characteristic mutational signature.Nature communications · 2020Article
- Predisposition to hematologic malignancies in patients with xeroderma pigmentosum.Haematologica · 2020Article
Corrections and comments
- Commented on by
Authors and funding
23 authors at 12 institutions in 2 countries.
Alain SarasinLaboratory of Genetic Instability and Oncogenesis, Unité Mixte de Recherche 8200 Centre National de la Recherche Scientifique, University Paris-Sud and Gustave Roussy, Villejuif, France.ORCID 0000-0002-2445-6016
Samuel QuentinInstitut National de la Santé et de la Recherche Médicale/CNRS U944/7212 and University Paris Diderot, University of Paris, France.
Nathalie DroinINSERM U1170, Gustave Roussy, Université Paris-Sud, Villejuif, France.
Mourad SahbatouFondation Jean Dausset, Centre d'Etude du Polymorphisme Humain, Paris, France.
Véronique SaadaDépartement de biologie et pathologie médicales, Gustave Roussy, Université Paris-Saclay, Villejuif, France.
Nathalie AugerDépartement de biologie et pathologie médicales, Gustave Roussy, Université Paris-Saclay, Villejuif, France.
Yannick BoursinBioinformatics Core Facility, Gustave Roussy, Villejuif, France.
Philippe DessenBioinformatics Core Facility, Gustave Roussy, Villejuif, France.
Anna RaimbaultInstitut National de la Santé et de la Recherche Médicale/CNRS U944/7212 and University Paris Diderot, University of Paris, France.
Vahid AsnafiInstitut Necker-Enfants Malades, INSERM U1151, Paris, France.
Jean-Luc SchmutzDepartment of Dermatology, Nancy University Hospital, Vandoeuvre-Lès-Nancy, France.
Alain TaïebDepartment of Dermatology, Bordeaux University Hospitals, and INSERM U1035, University of Bordeaux, Bordeaux, France.ORCID 0000-0002-0928-8608
Carlos F M MenckInstitute of Biomedical Sciences, University of Sao Paulo, Sao Paulo, Brazil.
Filippo RosselliLaboratory of Genetic Instability and Oncogenesis, Unité Mixte de Recherche 8200 Centre National de la Recherche Scientifique, University Paris-Sud and Gustave Roussy, Villejuif, France.
Laurianne Drieu La RochelleService d'Hématologie, CHU de Tours, Tours, France.
Caroline RobertDepartment of Dermatology, Gustave Roussy, Villejuif, France.
Flore Sicre de FontbruneCentre de référence Maladies Rares des Aplasies médullaires, Hôpital Saint-Louis et Robert Debré, Paris, France.
Marie SébertCentre de référence Maladies Rares des Aplasies médullaires, Hôpital Saint-Louis et Robert Debré, Paris, France.
Thierry LeblancPédiatrie hématologique, Hôpital Robert Debré, Paris, France.
Patricia KannoucheLaboratory of Genetic Instability and Oncogenesis, Unité Mixte de Recherche 8200 Centre National de la Recherche Scientifique, University Paris-Sud and Gustave Roussy, Villejuif, France.
Stéphane De BottonGustave Roussy, Université Paris-Saclay, Département d'hématologie, Villejuif, France.
Eric SolaryINSERM U1170, Gustave Roussy, Université Paris-Sud, Villejuif, France.
Jean SoulierInstitut National de la Santé et de la Recherche Médicale/CNRS U944/7212 and University Paris Diderot, University of Paris, France.ORCID 0000-0002-8734-5356
Centre National de la Recherche Scientifique · FRInstitut Gustave Roussy · FRUniversité Paris-Saclay · FRHôpital Saint-Louis · FRUniversité Paris-Sud · FRCentre Hospitalier Régional et Universitaire de Nancy · FRCentre Hospitalier Universitaire de Tours · FRFondation Jean Dausset-CEPH · FRHôpital Robert-Debré · FRInserm · FRUniversidade de São Paulo · BRUniversité de Bordeaux · FR
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Abnormal KaryotypeAdolescentAdultChildDNA-Binding ProteinsDNA RepairFemaleFounder EffectGenes, p53Genetic Predisposition to DiseaseHumansLeukemiaMaleMutationMyelodysplastic SyndromesTumor Suppressor Protein p53DNA-Binding ProteinsTP53 protein, humanTumor Suppressor Protein p53XPC protein, human
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.